Immunotherapy for Thymomas and Thymic Carcinomas: Current Status and Future Directions

A Rajan, AK Sivapiromrat, MJ McAdams - Cancers, 2024 - mdpi.com
Simple Summary Immune checkpoint inhibitors have revolutionized cancer therapy and
improved clinical outcomes. Immunotherapy is now increasingly combined with …
相关文章

Immunotherapy for Thymomas and Thymic Carcinomas: Current Status and Future Directions

A Rajan, AK Sivapiromrat, MJ McAdams - Cancers, 2024 - pubmed.ncbi.nlm.nih.gov
Thymic epithelial tumors are a histologically diverse group of cancers arising from the
epithelial compartment of the thymus. These tumors are characterized by a low tumor …
[HTML] nih.gov

[HTML][HTML] Immunotherapy for Thymomas and Thymic Carcinomas: Current Status and Future Directions

A Rajan, AK Sivapiromrat, MJ McAdams - Cancers, 2024 - ncbi.nlm.nih.gov
Thymic epithelial tumors are a histologically diverse group of cancers arising from the
epithelial compartment of the thymus. These tumors are characterized by a low tumor …

Immunotherapy for Thymomas and Thymic Carcinomas: Current Status and Future Directions.

A Rajan, AK Sivapiromrat, MJ McAdams - Cancers, 2024 - search.ebscohost.com
Abstract Simple Summary: Immune checkpoint inhibitors have revolutionized cancer therapy
and improved clinical outcomes. Immunotherapy is now increasingly combined with …

Immunotherapy for Thymomas and Thymic Carcinomas: Current Status and Future Directions.

A Rajan, AK Sivapiromrat, MJ McAdams - Cancers, 2024 - europepmc.org
Thymic epithelial tumors are a histologically diverse group of cancers arising from the
epithelial compartment of the thymus. These tumors are characterized by a low tumor …

Immunotherapy for Thymomas and Thymic Carcinomas: Current Status and Future Directions.

A Rajan, AK Sivapiromrat, MJ McAdams - Cancers, 2024 - europepmc.org
Thymic epithelial tumors are a histologically diverse group of cancers arising from the
epithelial compartment of the thymus. These tumors are characterized by a low tumor …